Dupixent is back on top of the list of Rx and over-the-counter (OTC) brands for the month of September, according to data released by iSpot.tv Tuesday afternoon.

Pharma brands generated billions of ad impressions on TV during the first half of 2023, according to a report released by iSpot.tv this week.

The eczema and asthma drug from Sanofi and Regeneron had an impressions share of voice (SOV) of 4.57% and 2.5 billion impressions overall, according to data from iSpot.tv that was released Thursday morning.

Flonase thrives during allergy season, with the brand making the top 10 list of OTC and Rx brands during the month of April, according to data from iSpot.tv.

The treatment for Crohn’s disease, psoriasis and psoriatic arthritis generated an impressions share of voice (SOV) of 7.27% and 2.4 billion impressions during the month, according to data released by iSpot.tv Friday morning.

Vicks reclaimed its title as the top Rx and over-the-counter (OTC) brand for ad impressions during February, according to data released by iSpot.tv Tuesday morning.

Vicks, best known for its cough and cold relief drugs, had the most impressions of any Rx or OTC pharma brand last month, according to data from iSpot.tv released Monday afternoon, while severe asthma treatment Dupixent led the way for 2022 as a whole.

Vicks achieved an impressions share of voice (SOV) of 7.17% among Rx brands, far ahead of second-place finisher Rinvoq at 4.26%. Vicks also had an estimated national TV ad spend of $16.2 million during the month, favoring CBS as their top network and The Price is Right as their top show.